Global Pharmaceutical Manufacturing Industry 2022-2032 by Formulation, Route of Administration, Consumer Group, Therapeutic Application, Drug Type, Distribution Channel, Manufacturing Facility, and Region: Trend Forecast and Growth Opportunity

December 2023 | 228 pages | ID: G81C657459BBEN
GMD Research

Abstracts

Global pharmaceutical manufacturing industry market will reach $25.77 billion by 2032, growing by 9.3% annually over 2022-2032. The growth is driven by the increased drug approvals, increasing prevalence of chronic ailments, growing geriatric population, high R&D investment in pharmaceutical industry, increasing per capita healthcare expenditure, and technological advancements in manufacturing processes.

Highlighted with 142 tables and 105 figures, this 228-page report “Global Pharmaceutical Manufacturing Industry 2022-2032 by Formulation, Route of Administration, Consumer Group, Therapeutic Application, Drug Type, Distribution Channel, Manufacturing Facility, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global pharmaceutical manufacturing industry market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2020-2022 and provides forecast from 2023 till 2032 with 2022 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces

The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify global pharmaceutical manufacturing industry market in every aspect of the classification from perspectives of Formulation, Route of Administration, Consumer Group, Therapeutic Application, Drug Type, Distribution Channel, Manufacturing Facility, and Region.

Based on Formulation, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

• Tablets
• Capsules
• Injectable
• Sprays
• Suspensions
• Powders
• Other Formulations

Based on Route of Administration, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

• Oral Medicine
• Topical Medicine
• Parenteral Medicine
• Inhalations
• Other Routes of Administration

By Consumer Group, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

• Children & Adolescents (17 years old and below)
• Adults (18-64 years old)
• Geriatric (65 years old and above)

By Therapeutic Application, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

• Cardiovascular Diseases
• Pain
• Diabetes
• Cancer
• Respiratory Diseases
• Neurological Diseases
• Orthopedics
• Other Applications

By Drug Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

• Branded Prescription Drugs
• Generic Prescription Drugs
• OTC Drugs

By Distribution Channel, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

• Retail Channels
• Non-retail Channels

By Manufacturing Facility, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

• In-house Facility
• Outsourced Facility

Geographically, the following regions together with the listed national/local markets are fully investigated:

• North America (U.S., Canada, and Mexico)
• Europe (Germany, UK, France, Spain, Italy, Netherlands, Rest of Europe; Rest of Europe is further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
• South America (Brazil, Chile, Argentina, Rest of South America)
• MEA (UAE, Saudi Arabia, South Africa, and Rest of MEA)

For each region and country, detailed analysis and annual revenue ($ mn) are available for 2022-2032. The breakdown of all regional markets by country and the breakdown of each national market by Formulation, Route of Administration, and Drug Type over the forecast years are also included.

The report also covers the current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:

Abbott Laboratories

Aenova Group

Amgen Inc.

AstraZeneca

Catalent Inc.

Eli Lilly and Company

F. Hoffmann-La Roche Ltd.

Gilead Sciences Inc.

GlaxoSmithKline plc

Johnson & Johnson

Lonza Group

Lupin Limited

Merck & Co., Inc.

Novartis AG

Novo Nordisk

Patheon Inc.

Pfizer CentreSource

Sanofi SA

Takeda

(Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)

Contents

1 INTRODUCTION

1.1 Industry Definition and Research Scope
  1.1.1 Industry Definition
  1.1.2 Research Scope
1.2 Research Methodology
  1.2.1 Overview of Market Research Methodology
  1.2.2 Market Assumption
  1.2.3 Secondary Data
  1.2.4 Primary Data
  1.2.5 Data Filtration and Model Design
  1.2.6 Market Size/Share Estimation
  1.2.7 Research Limitations
1.3 Executive Summary

2 MARKET OVERVIEW AND DYNAMICS

2.1 Market Size and Forecast
  2.1.1 Impact of COVID-19 on World Economy
  2.1.2 Impact of COVID-19 on the Market
  2.1.3 Impact of Russia-Ukraine Conflict: War Slows Economic Recovery
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis

3 SEGMENTATION OF GLOBAL MARKET BY FORMULATION

3.1 Market Overview by Formulation
3.2 Tablets
3.3 Capsules
3.4 Injectable
3.5 Sprays
3.6 Suspensions
3.7 Powders
3.8 Other Formulations

4 SEGMENTATION OF GLOBAL MARKET BY ROUTE OF ADMINISTRATION

4.1 Market Overview by Route of Administration
4.2 Oral Medicine
4.3 Topical Medicine
4.4 Parenteral Medicine
4.5 Inhalations
4.6 Other Routes of Administration

5 SEGMENTATION OF GLOBAL MARKET BY CONSUMER GROUP

5.1 Market Overview by Consumer Group
5.2 Children & Adolescents (17 years old and below)
5.3 Adults (18-64 years old)
5.4 Geriatric (65 years old and above)

6 SEGMENTATION OF GLOBAL MARKET BY THERAPEUTIC APPLICATION

6.1 Market Overview by Therapeutic Application
6.2 Cardiovascular Diseases
6.3 Pain
6.4 Diabetes
6.5 Cancer
6.6 Respiratory Diseases
6.7 Neurological Diseases
6.8 Orthopedics
6.9 Other Applications

7 SEGMENTATION OF GLOBAL MARKET BY DRUG TYPE

7.1 Market Overview by Drug Type
7.2 Branded Prescription Drugs
7.3 Generic Prescription Drugs
7.4 OTC Drugs

8 SEGMENTATION OF GLOBAL MARKET BY DISTRIBUTION CHANNEL

8.1 Market Overview by Distribution Channel
8.2 Retail Channels
8.3 Non-retail Channels

9 SEGMENTATION OF GLOBAL MARKET BY MANUFACTURING FACILITY

9.1 Market Overview by Manufacturing Facility
9.2 In-house Facility
9.3 Outsourced Facility

10 SEGMENTATION OF GLOBAL MARKET BY REGION

10.1 Geographic Market Overview 2022-2032
10.2 North America Market 2022-2032 by Country
  10.2.1 Overview of North America Market
  10.2.2 U.S.
  10.2.3 Canada
  10.2.4 Mexico
10.3 European Market 2022-2032 by Country
  10.3.1 Overview of European Market
  10.3.2 Germany
  10.3.3 U.K.
  10.3.4 France
  10.3.5 Spain
  10.3.6 Italy
  10.3.7 Netherlands
  10.3.8 Rest of European Market
10.4 Asia-Pacific Market 2022-2032 by Country
  10.4.1 Overview of Asia-Pacific Market
  10.4.2 Japan
  10.4.3 China
  10.4.4 Australia
  10.4.5 India
  10.4.6 South Korea
  10.4.7 Rest of APAC Region
10.5 South America Market 2022-2032 by Country
  10.5.1 Argentina
  10.5.2 Brazil
  10.5.3 Chile
  10.5.4 Rest of South America Market
10.6 MEA Market 2022-2032 by Country
  10.6.1 UAE
  10.6.2 Saudi Arabia
  10.6.3 South Africa
  10.6.4 Other National Markets

11 COMPETITIVE LANDSCAPE

11.1 Overview of Key Vendors
11.2 New Product Launch, Partnership, Investment, and M&A
11.3 Company Profiles
Abbott Laboratories
Aenova Group
Amgen Inc.
AstraZeneca
Catalent Inc.
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
Gilead Sciences Inc.
GlaxoSmithKline plc
Johnson & Johnson
Lonza Group
Lupin Limited
Merck & Co., Inc.
Novartis AG
Novo Nordisk
Patheon Inc.
Pfizer CentreSource
Sanofi SA
Takeda
RELATED REPORTS

List Of Tables

LIST OF TABLES

Table 1. Snapshot of Global Pharmaceutical Manufacturing Industry in Balanced Perspective, 2022-2032
Table 2. World Pharmaceuticals Output by Region, 2022-2025, annual percentage change
Table 3. World Economic Outlook, 2021-2031
Table 4. World Economic Outlook, 2021-2023
Table 5. Scenarios for Economic Impact of Ukraine Crisis
Table 6. World Health Spending by Region, $ bn, 2013-2020
Table 7. Main Product Trends and Market Opportunities in Global Pharmaceutical Manufacturing Industry
Table 8. Global Pharmaceutical Manufacturing Industry by Formulation, 2022-2032, $ mn
Table 9. Global Pharmaceutical Manufacturing Industry by Route of Administration, 2022-2032, $ mn
Table 10. Global Pharmaceutical Manufacturing Industry by Consumer Group, 2022-2032, $ mn
Table 11. Global Pharmaceutical Manufacturing Industry by Therapeutic Application, 2022-2032, $ mn
Table 12. Global Pharmaceutical Manufacturing Industry by Drug Type, 2022-2032, $ mn
Table 13. Global Pharmaceutical Manufacturing Industry by Distribution Channel, 2022-2032, $ mn
Table 14. Global Pharmaceutical Manufacturing Industry by Manufacturing Facility, 2022-2032, $ mn
Table 15. Global Pharmaceutical Manufacturing Industry by Region, 2022-2032, $ mn
Table 16. Leading National Pharmaceutical Manufacturing Industry, 2022 and 2032, $ mn
Table 17. North America Pharmaceutical Manufacturing Industry by Country, 2022-2032, $ mn
Table 18. U.S. Pharmaceutical Manufacturing Industry by Formulation, 2022-2032, $ mn
Table 19. U.S. Pharmaceutical Manufacturing Industry by Route of Administration, 2022-2032, $ mn
Table 20. U.S. Pharmaceutical Manufacturing Industry by Drug Type, 2022-2032, $ mn
Table 21. Canada Pharmaceutical Manufacturing Industry by Formulation, 2022-2032, $ mn
Table 22. Canada Pharmaceutical Manufacturing Industry by Route of Administration, 2022-2032, $ mn
Table 23. Canada Pharmaceutical Manufacturing Industry by Drug Type, 2022-2032, $ mn
Table 24. Mexico Pharmaceutical Manufacturing Industry by Formulation, 2022-2032, $ mn
Table 25. Mexico Pharmaceutical Manufacturing Industry by Route of Administration, 2022-2032, $ mn
Table 26. Mexico Pharmaceutical Manufacturing Industry by Drug Type, 2022-2032, $ mn
Table 27. Europe Pharmaceutical Manufacturing Industry by Country, 2022-2032, $ mn
Table 28. Germany Pharmaceutical Manufacturing Industry by Formulation, 2022-2032, $ mn
Table 29. Germany Pharmaceutical Manufacturing Industry by Route of Administration, 2022-2032, $ mn
Table 30. Germany Pharmaceutical Manufacturing Industry by Drug Type, 2022-2032, $ mn
Table 31. U.K. Pharmaceutical Manufacturing Industry by Formulation, 2022-2032, $ mn
Table 32. U.K. Pharmaceutical Manufacturing Industry by Route of Administration, 2022-2032, $ mn
Table 33. U.K. Pharmaceutical Manufacturing Industry by Drug Type, 2022-2032, $ mn
Table 34. France Pharmaceutical Manufacturing Industry by Formulation, 2022-2032, $ mn
Table 35. France Pharmaceutical Manufacturing Industry by Route of Administration, 2022-2032, $ mn
Table 36. France Pharmaceutical Manufacturing Industry by Drug Type, 2022-2032, $ mn
Table 37. Spain Pharmaceutical Manufacturing Industry by Formulation, 2022-2032, $ mn
Table 38. Spain Pharmaceutical Manufacturing Industry by Route of Administration, 2022-2032, $ mn
Table 39. Spain Pharmaceutical Manufacturing Industry by Drug Type, 2022-2032, $ mn
Table 40. Italy Pharmaceutical Manufacturing Industry by Formulation, 2022-2032, $ mn
Table 41. Italy Pharmaceutical Manufacturing Industry by Route of Administration, 2022-2032, $ mn
Table 42. Italy Pharmaceutical Manufacturing Industry by Drug Type, 2022-2032, $ mn
Table 43. Netherlands Pharmaceutical Manufacturing Industry by Formulation, 2022-2032, $ mn
Table 44. Netherlands Pharmaceutical Manufacturing Industry by Route of Administration, 2022-2032, $ mn
Table 45. Netherlands Pharmaceutical Manufacturing Industry by Drug Type, 2022-2032, $ mn
Table 46. Pharmaceutical Manufacturing Industry in Rest of Europe by Country, 2022-2032, $ mn
Table 47. APAC Pharmaceutical Manufacturing Industry by Country, 2022-2032, $ mn
Table 48. Japan Pharmaceutical Manufacturing Industry by Formulation, 2022-2032, $ mn
Table 49. Japan Pharmaceutical Manufacturing Industry by Route of Administration, 2022-2032, $ mn
Table 50. Japan Pharmaceutical Manufacturing Industry by Drug Type, 2022-2032, $ mn
Table 51. China Pharmaceutical Manufacturing Industry by Formulation, 2022-2032, $ mn
Table 52. China Pharmaceutical Manufacturing Industry by Route of Administration, 2022-2032, $ mn
Table 53. China Pharmaceutical Manufacturing Industry by Drug Type, 2022-2032, $ mn
Table 54. Australia Pharmaceutical Manufacturing Industry by Formulation, 2022-2032, $ mn
Table 55. Australia Pharmaceutical Manufacturing Industry by Route of Administration, 2022-2032, $ mn
Table 56. Australia Pharmaceutical Manufacturing Industry by Drug Type, 2022-2032, $ mn
Table 57. India Pharmaceutical Manufacturing Industry by Formulation, 2022-2032, $ mn
Table 58. India Pharmaceutical Manufacturing Industry by Route of Administration, 2022-2032, $ mn
Table 59. India Pharmaceutical Manufacturing Industry by Drug Type, 2022-2032, $ mn
Table 60. South Korea Pharmaceutical Manufacturing Industry by Formulation, 2022-2032, $ mn
Table 61. South Korea Pharmaceutical Manufacturing Industry by Route of Administration, 2022-2032, $ mn
Table 62. South Korea Pharmaceutical Manufacturing Industry by Drug Type, 2022-2032, $ mn
Table 63. Pharmaceutical Manufacturing Industry in Rest of APAC by Country/Region, 2022-2032, $ mn
Table 64. South America Pharmaceutical Manufacturing Industry by Country, 2022-2032, $ mn
Table 65. Argentina Pharmaceutical Manufacturing Industry by Formulation, 2022-2032, $ mn
Table 66. Argentina Pharmaceutical Manufacturing Industry by Route of Administration, 2022-2032, $ mn
Table 67. Argentina Pharmaceutical Manufacturing Industry by Drug Type, 2022-2032, $ mn
Table 68. Brazil Pharmaceutical Manufacturing Industry by Formulation, 2022-2032, $ mn
Table 69. Brazil Pharmaceutical Manufacturing Industry by Route of Administration, 2022-2032, $ mn
Table 70. Brazil Pharmaceutical Manufacturing Industry by Drug Type, 2022-2032, $ mn
Table 71. Chile Pharmaceutical Manufacturing Industry by Formulation, 2022-2032, $ mn
Table 72. Chile Pharmaceutical Manufacturing Industry by Route of Administration, 2022-2032, $ mn
Table 73. Chile Pharmaceutical Manufacturing Industry by Drug Type, 2022-2032, $ mn
Table 74. MEA Pharmaceutical Manufacturing Industry by Country, 2022-2032, $ mn
Table 75. UAE Pharmaceutical Manufacturing Industry by Formulation, 2022-2032, $ mn
Table 76. UAE Pharmaceutical Manufacturing Industry by Route of Administration, 2022-2032, $ mn
Table 77. UAE Pharmaceutical Manufacturing Industry by Drug Type, 2022-2032, $ mn
Table 78. Saudi Arabia Pharmaceutical Manufacturing Industry by Formulation, 2022-2032, $ mn
Table 79. Saudi Arabia Pharmaceutical Manufacturing Industry by Route of Administration, 2022-2032, $ mn
Table 80. Saudi Arabia Pharmaceutical Manufacturing Industry by Drug Type, 2022-2032, $ mn
Table 81. South Africa Pharmaceutical Manufacturing Industry by Formulation, 2022-2032, $ mn
Table 82. South Africa Pharmaceutical Manufacturing Industry by Route of Administration, 2022-2032, $ mn
Table 83. South Africa Pharmaceutical Manufacturing Industry by Drug Type, 2022-2032, $ mn
Table 84. Abbott Laboratories: Company Snapshot
Table 85. Abbott Laboratories: Business Segmentation
Table 86. Abbott Laboratories: Product Portfolio
Table 87. Aenova Group: Company Snapshot
Table 88. Aenova Group: Business Segmentation
Table 89. Aenova Group: Revenue by Product, 2018-2019, thousand Euro
Table 90. Aenova Group: Recent Developments
Table 91. Amgen Inc.: Company Snapshot
Table 92. Amgen Inc.: Approved Drugs or Therapeutic Biologicals
Table 93. Astrazeneca: Company Snapshot
Table 94. Catalent Inc.: Company Snapshot
Table 95. Catalent Inc.: Business Segmentation in 2018
Table 96. Catalent Inc.: Product Portfolio
Table 97. Catalent Inc.: Revenue, 2018-2020, $ million
Table 98. Catalent Inc.: Revenue by Region in 2018
Table 99. Eli Lilly and Company: Company Snapshot
Table 100. Eli Lilly and Company: Pharmaceutical Brands
Table 101. F. Hoffmann-La Roche: Company Snapshot
Table 102. F. Hoffmann-La Roche: Business Segmentation
Table 103. F. Hoffmann-La Roche: Revenue, 2017-2019, $ bn
Table 104. Gilead Sciences: Company Snapshot
Table 105. Gilead Sciences: Main Products
Table 106. GlaxoSmithKline: Company Snapshot
Table 107. GlaxoSmithKline: Business Segmentation
Table 108. GlaxoSmithKline: Product Portfolio
Table 109. GlaxoSmithKline: Revenue, 2018-2020, $ bn
Table 110. Johnson & Johnson: Company Snapshot
Table 111. Johnson & Johnson: Business Segments
Table 112. Lonza Group: Company Snapshot
Table 113. Lonza Group: Business Segmentation in 2018
Table 114. Lonza Group: Product Portfolio
Table 115. Lonza Group: Revenue by Region in 2018
Table 116. Lupin Limited: Company Snapshot
Table 117. Lupin Limited: Business Segmentation
Table 118. Merck & Co., Inc.: Company Snapshot
Table 119. Merck & Co., Inc.: Business Segmentation
Table 120. Merck & Co., Inc.: Revenue, 2018-2020, $ bn
Table 121. Novartis International AG: Company Snapshot
Table 122. Novartis International AG: Business Segmentation
Table 123. Novartis International AG: Revenue, 2017-2019, $ bn
Table 124. Novo Nordisk: Company Snapshot
Table 125. Novo Nordisk: Product Portfolio
Table 126. Patheon Inc.: Company Snapshot
Table 127. Patheon Inc.: Business Segmentation in 2018
Table 128. Patheon Inc.: Product Portfolio
Table 129. Patheon Inc.: Revenue, 2017-2019, $ billion
Table 130. Patheon Inc.: Revenue by Region in 2018
Table 131. Patheon Inc.: Recent Developments
Table 132. Pfizer CentreSource: Company Snapshot
Table 133. Pfizer CentreSource: Business Segmentation in 2018
Table 134. Pfizer CentreSource: Product Portfolio
Table 135. Pfizer CentreSource: Revenue, 2017-2019, $ billion
Table 136. Pfizer CentreSource: Revenue by Region in 2018
Table 137. Hospira, Inc. (a subsidiary of Pfizer): Company Snapshot
Table 138. Pfizer CentreSource: Recent Developments
Table 139. Sanofi: Company Snapshot
Table 140. Sanofi: Business Segmentation
Table 141. Sanofi: Revenue, 2018-2020, $ bn
Table 142. Takeda Pharmaceutical Co. Ltd.: Company Snapshot

List Of Figures

LIST OF FIGURES

Figure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2022-2032
Figure 4. Global Pharmaceutical Manufacturing Industry, 2022-2032, $ mn
Figure 5. World Healthcare Services Production, annual percentage change
Figure 6. Impact of COVID-19 on Business
Figure 7. Primary Drivers and Impact Factors of Global Pharmaceutical Manufacturing Industry
Figure 8. Trends in the Approval of Cancer Therapies by FDA in the Twenty-First Century
Figure 9. Leading Causes of Death in the World, 2000 and 2019, million
Figure 10. Worldwide Geriatric Population (60 years and above) by Region, 2015 & 2030, million
Figure 11. World Population 65 and Over, % of Total Population, 1950-2060
Figure 12. Primary Restraints and Impact Factors of Global Pharmaceutical Manufacturing Industry
Figure 13. Investment Opportunity Analysis
Figure 14. Porter’s Fiver Forces Analysis of Global Pharmaceutical Manufacturing Industry
Figure 15. Breakdown of Global Pharmaceutical Manufacturing Industry by Formulation, 2022-2032, % of Revenue
Figure 16. Global Addressable Market Cap in 2023-2032 by Formulation, Value ($ mn) and Share (%)
Figure 17. Global Pharmaceutical Manufacturing Industry by Formulation: Tablets, 2022-2032, $ mn
Figure 18. Global Pharmaceutical Manufacturing Industry by Formulation: Capsules, 2022-2032, $ mn
Figure 19. Global Pharmaceutical Manufacturing Industry by Formulation: Injectable, 2022-2032, $ mn
Figure 20. Global Pharmaceutical Manufacturing Industry by Formulation: Sprays, 2022-2032, $ mn
Figure 21. Global Pharmaceutical Manufacturing Industry by Formulation: Suspensions, 2022-2032, $ mn
Figure 22. Global Pharmaceutical Manufacturing Industry by Formulation: Powders, 2022-2032, $ mn
Figure 23. Global Pharmaceutical Manufacturing Industry by Formulation: Other Formulations, 2022-2032, $ mn
Figure 24. Breakdown of Global Pharmaceutical Manufacturing Industry by Route of Administration, 2022-2032, % of Sales Revenue
Figure 25. Global Addressable Market Cap in 2023-2032 by Route of Administration, Value ($ mn) and Share (%)
Figure 26. Global Pharmaceutical Manufacturing Industry by Route of Administration: Oral Medicine, 2022-2032, $ mn
Figure 27. Global Pharmaceutical Manufacturing Industry by Route of Administration: Topical Medicine, 2022-2032, $ mn
Figure 28. Global Pharmaceutical Manufacturing Industry by Route of Administration: Parenteral Medicine, 2022-2032, $ mn
Figure 29. Global Pharmaceutical Manufacturing Industry by Route of Administration: Inhalations, 2022-2032, $ mn
Figure 30. Global Pharmaceutical Manufacturing Industry by Route of Administration: Other Routes of Administration, 2022-2032, $ mn
Figure 31. Breakdown of Global Pharmaceutical Manufacturing Industry by Consumer Group, 2022-2032, % of Sales Revenue
Figure 32. Global Addressable Market Cap in 2023-2032 by Consumer Group, Value ($ mn) and Share (%)
Figure 33. Global Pharmaceutical Manufacturing Industry by Consumer Group: Children & Adolescents (17 years old and below), 2022-2032, $ mn
Figure 34. Global Pharmaceutical Manufacturing Industry by Consumer Group: Adults (18-64 years old), 2022-2032, $ mn
Figure 35. Global Pharmaceutical Manufacturing Industry by Consumer Group: Geriatric (65 years old and above), 2022-2032, $ mn
Figure 36. Breakdown of Global Pharmaceutical Manufacturing Industry by Therapeutic Application, 2022-2032, % of Revenue
Figure 37. Global Addressable Market Cap in 2023-2032 by Therapeutic Application, Value ($ mn) and Share (%)
Figure 38. Global Pharmaceutical Manufacturing Industry by Therapeutic Application: Cardiovascular Diseases, 2022-2032, $ mn
Figure 39. Global Pharmaceutical Manufacturing Industry by Therapeutic Application: Pain, 2022-2032, $ mn
Figure 40. Global Pharmaceutical Manufacturing Industry by Therapeutic Application: Diabetes, 2022-2032, $ mn
Figure 41. Global Pharmaceutical Manufacturing Industry by Therapeutic Application: Cancer, 2022-2032, $ mn
Figure 42. Global Pharmaceutical Manufacturing Industry by Therapeutic Application: Respiratory Diseases, 2022-2032, $ mn
Figure 43. Global Pharmaceutical Manufacturing Industry by Therapeutic Application: Neurological Diseases, 2022-2032, $ mn
Figure 44. Global Pharmaceutical Manufacturing Industry by Therapeutic Application: Orthopedics, 2022-2032, $ mn
Figure 45. Global Pharmaceutical Manufacturing Industry by Therapeutic Application: Other Applications, 2022-2032, $ mn
Figure 46. Breakdown of Global Pharmaceutical Manufacturing Industry by Drug Type, 2022-2032, % of Revenue
Figure 47. Global Addressable Market Cap in 2023-2032 by Drug Type, Value ($ mn) and Share (%)
Figure 48. Global Pharmaceutical Manufacturing Industry by Drug Type: Branded Prescription Drugs, 2022-2032, $ mn
Figure 49. Global Pharmaceutical Manufacturing Industry by Drug Type: Generic Prescription Drugs, 2022-2032, $ mn
Figure 50. Global Pharmaceutical Manufacturing Industry by Drug Type: OTC Drugs, 2022-2032, $ mn
Figure 51. Breakdown of Global Pharmaceutical Manufacturing Industry by Distribution Channel, 2022-2032, % of Revenue
Figure 52. Global Addressable Market Cap in 2023-2032 by Distribution Channel, Value ($ mn) and Share (%)
Figure 53. Global Pharmaceutical Manufacturing Industry by Distribution Channel: Retail Channels, 2022-2032, $ mn
Figure 54. Global Pharmaceutical Manufacturing Industry by Distribution Channel: Non-retail Channels, 2022-2032, $ mn
Figure 55. Breakdown of Global Pharmaceutical Manufacturing Industry by Manufacturing Facility, 2022-2032, % of Revenue
Figure 56. Global Addressable Market Cap in 2023-2032 by Manufacturing Facility, Value ($ mn) and Share (%)
Figure 57. Global Pharmaceutical Manufacturing Industry by Manufacturing Facility: In-house Facility, 2022-2032, $ mn
Figure 58. Global Pharmaceutical Manufacturing Industry by Manufacturing Facility: Outsourced Facility, 2022-2032, $ mn
Figure 59. Global Market Snapshot by Region
Figure 60. Geographic Spread of Worldwide Pharmaceutical Manufacturing Industry, 2022-2032, % of Sales Revenue
Figure 61. Global Addressable Market Cap in 2023-2032 by Region, Value ($ mn) and Share (%)
Figure 62. North American Pharmaceutical Manufacturing Industry, 2022-2032, $ mn
Figure 63. Breakdown of North America Pharmaceutical Manufacturing Industry by Country, 2022 and 2032, % of Revenue
Figure 64. Contribution to North America 2023-2032 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 65. U.S. Pharmaceutical Manufacturing Industry, 2022-2032, $ mn
Figure 66. Sources of API Manufacturing by Product Area in U.S., as of May 2021
Figure 67. Manufacturing Locations of Essential Medicines in U.S., as of May 2021
Figure 68. Count of High-Capacity API Sites in U.S. in 2021
Figure 69. FDA-Approved API Manufacturing Sites in U.S., 2016-2021
Figure 70. Canada Pharmaceutical Manufacturing Industry, 2022-2032, $ mn
Figure 71. Pharmaceutical Manufacturing Industry in Mexico, 2022-2032, $ mn
Figure 72. European Pharmaceutical Manufacturing Industry, 2022-2032, $ mn
Figure 73. Breakdown of European Pharmaceutical Manufacturing Industry by Country, 2022 and 2032, % of Revenue
Figure 74. Contribution to Europe 2023-2032 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 75. Pharmaceutical Manufacturing Industry in Germany, 2022-2032, $ mn
Figure 76. Pharmaceutical Manufacturing Industry in U.K., 2022-2032, $ mn
Figure 77. Pharmaceutical Manufacturing Industry in France, 2022-2032, $ mn
Figure 78. Pharmaceutical Manufacturing Industry in Spain, 2022-2032, $ mn
Figure 79. Pharmaceutical Manufacturing Industry in Italy, 2022-2032, $ mn
Figure 80. Pharmaceutical Manufacturing Industry in Netherlands, 2022-2032, $ mn
Figure 81. Pharmaceutical Manufacturing Industry in Rest of Europe, 2022-2032, $ mn
Figure 82. Asia-Pacific Pharmaceutical Manufacturing Industry, 2022-2032, $ mn
Figure 83. Breakdown of APAC Pharmaceutical Manufacturing Industry by Country, 2022 and 2032, % of Revenue
Figure 84. Contribution to APAC 2023-2032 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 85. Pharmaceutical Manufacturing Industry in Japan, 2022-2032, $ mn
Figure 86. Pharmaceutical Manufacturing Industry in China, 2022-2032, $ mn
Figure 87. Pharmaceutical Manufacturing Industry in Australia, 2022-2032, $ mn
Figure 88. Pharmaceutical Manufacturing Industry in India, 2022-2032, $ mn
Figure 89. Pharmaceutical Manufacturing Industry in South Korea, 2022-2032, $ mn
Figure 90. Pharmaceutical Manufacturing Industry in Rest of APAC, 2022-2032, $ mn
Figure 91. South America Pharmaceutical Manufacturing Industry, 2022-2032, $ mn
Figure 92. Breakdown of South America Pharmaceutical Manufacturing Industry by Country, 2022 and 2032, % of Revenue
Figure 93. Contribution to South America 2023-2032 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 94. Pharmaceutical Manufacturing Industry in Argentina, 2022-2032, $ mn
Figure 95. Pharmaceutical Manufacturing Industry in Brazil, 2022-2032, $ mn
Figure 96. Pharmaceutical Manufacturing Industry in Chile, 2022-2032, $ mn
Figure 97. Pharmaceutical Manufacturing Industry in Rest of South America, 2022-2032, $ mn
Figure 98. Pharmaceutical Manufacturing Industry in Middle East and Africa (MEA), 2022-2032, $ mn
Figure 99. Breakdown of MEA Pharmaceutical Manufacturing Industry by Country, 2022 and 2032, % of Revenue
Figure 100. Contribution to MEA 2023-2032 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 101. Pharmaceutical Manufacturing Industry in UAE, 2022-2032, $ mn
Figure 102. Pharmaceutical Manufacturing Industry in Saudi Arabia, 2022-2032, $ mn
Figure 103. Pharmaceutical Manufacturing Industry in South Africa, 2022-2032, $ mn
Figure 104. Growth Stage of Global 3D Printing Industry over the Forecast Period
Figure 105. Top products of AstraZeneca based on revenue from 2016 to 2019 (in million U.S. dollars)